LYFE MANUFACTURING CENTER Trademark
Trademark Overview
On Monday, March 15, 2021, a trademark application was filed for LYFE MANUFACTURING CENTER with the United States Patent and Trademark Office. The USPTO has given the LYFE MANUFACTURING CENTER trademark a serial number of 90580472. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, January 6, 2023. This trademark is owned by Lyell Immunopharma, Inc.. The LYFE MANUFACTURING CENTER trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:
Custom manufacture of pharmaceuticals
Pharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and infectious diseases; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; scientific research and development; scientific laboratory services; medical and scientific research
General Information
| Serial Number | 90580472 |
| Word Mark | LYFE MANUFACTURING CENTER |
| Filing Date | Monday, March 15, 2021 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Friday, January 6, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Custom manufacture of pharmaceuticals |
| Pseudo Mark | LIFE MANUFACTURING CENTER |
| Disclaimer with Predetermined Text | "MANUFACTURING CENTER" |
| Goods and Services | Pharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and infectious diseases; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; scientific research and development; scientific laboratory services; medical and scientific research |
Classification Information
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, June 15, 2021 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, June 15, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Lyell Immunopharma, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080 |
Trademark Events
| Event Date | Event Description |
| Monday, January 9, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Friday, January 6, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Friday, January 6, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Tuesday, May 31, 2022 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Tuesday, May 31, 2022 | FINAL REFUSAL E-MAILED |
| Tuesday, May 31, 2022 | FINAL REFUSAL WRITTEN |
| Tuesday, April 12, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, April 11, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, April 11, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, October 14, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, October 14, 2021 | NON-FINAL ACTION E-MAILED |
| Thursday, October 14, 2021 | NON-FINAL ACTION WRITTEN |
| Wednesday, October 13, 2021 | ASSIGNED TO EXAMINER |
| Friday, October 1, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, October 1, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, October 1, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, June 15, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, March 18, 2021 | NEW APPLICATION ENTERED IN TRAM |
